- Home
- CWAN vs LNTH Comparison
CWAN vs LNTH Comparison
Compare CWAN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWAN
- LNTH
- Stock Information
- Founded
- CWAN 2004
- LNTH 1956
- Country
- CWAN United States
- LNTH United States
- Employees
- CWAN N/A
- LNTH N/A
- Industry
- CWAN Computer Software: Prepackaged Software
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CWAN Technology
- LNTH Health Care
- Exchange
- CWAN Nasdaq
- LNTH Nasdaq
- Market Cap
- CWAN 7.3B
- LNTH 7.5B
- IPO Year
- CWAN 2021
- LNTH 2015
- Fundamental
- Price
- CWAN $24.22
- LNTH $77.61
- Analyst Decision
- CWAN Buy
- LNTH Strong Buy
- Analyst Count
- CWAN 9
- LNTH 5
- Target Price
- CWAN $32.44
- LNTH $133.80
- AVG Volume (30 Days)
- CWAN 3.5M
- LNTH 1.3M
- Earning Date
- CWAN 04-30-2025
- LNTH 05-07-2025
- Dividend Yield
- CWAN N/A
- LNTH N/A
- EPS Growth
- CWAN N/A
- LNTH N/A
- EPS
- CWAN 1.71
- LNTH 3.53
- Revenue
- CWAN $475,948,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- CWAN $21.92
- LNTH $5.81
- Revenue Next Year
- CWAN $18.92
- LNTH $12.26
- P/E Ratio
- CWAN $14.23
- LNTH $22.69
- Revenue Growth
- CWAN 23.21
- LNTH 12.53
- 52 Week Low
- CWAN $17.42
- LNTH $74.34
- 52 Week High
- CWAN $35.71
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- CWAN 55.48
- LNTH 26.85
- Support Level
- CWAN $23.91
- LNTH $78.61
- Resistance Level
- CWAN $24.63
- LNTH $83.60
- Average True Range (ATR)
- CWAN 0.68
- LNTH 3.75
- MACD
- CWAN 0.35
- LNTH -3.08
- Stochastic Oscillator
- CWAN 84.93
- LNTH 0.35
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.